Archives for December 4, 2019

NEWS IN BRIEF

CMAB to provide development service for ‘first in class’ Chinese-developed biologic

CMAB Biopharma will provide development and manufacturing services for Fapon Biopharma’s potential oncology drug product.

Astellas in $3bn gene therapy acquisition, highlights manufacturing capabilities

Astellas agrees deal for Audentes, which has a pipeline of gene therapies and large-scale manufacturing capabilities.